DACARZER 200mg

Dacarzer -200mg

Dacarzer 200mg injection consists of Dacarbazine IP 200 mg

Classification: Anticancer, Antineoplastic

Dacarzer by Aprazer – Proven Oncology Care Made Accessible

Aprazer’s Dacarzer aligns with the global therapeutic standards listed in the WHO essential medicine lists, making it a trusted and eligible choice for national oncology programs and public health worldwide.

Affordability and proven efficacy make it a strong fit for budget-sensitive public health systems.

As the leading oncology medicine manufacturer, Aprazer develops the largest range of oncology medicines, both oral and injectable.

• • WHO- GMP certified.
• • Assured therapeutic efficacy and quality.
• • Available globally in 50+ countries.

Dacarzer is Widely Used to Treat Cancers of the Lymph and the Skin

• • Skin cancer
• • Hodgkin lymphoma
• • Soft tissue sarcoma
• • Brain tumors
• • Breast cancer
• • Lung cancer

How does it work?

It alkylates DNA and inhibits replication and synthesis, ultimately leading to cell death.

Contraindications:

• • It should be used cautiously in patients who have had hypersensitivity in the past or people having hepatic and renal insufficiency.
• • Pregnant and breastfeeding women.

Toxicities:

• • Myelosuppression (Bone Marrow Suppression)
• • Hepato-toxicity
• • Secondary malignancies
• • Local tissue necrosis

Precautions:

• • Renal and hepatic compromised patients.
• • Immune dysfunctions
• • Bone marrow disorders
• • Bleeding disorders
• • Pre-existing GIT disorders

Common side effects:

• • Nausea and vomiting
• • Reduced appetite
• • High risk of infection
• • Bruising and bleeding
• • Anemia (low red blood cell count)
• • Photosensitivity

Warning:

To be used under the supervision of a medical practitioner or an oncology care specialist.

Dacarbazine given intravenously may sometimes leak outside the vein, causing pain, tissue damage, local bruising, and flare.

Storage

It should be stored at 2-8 degrees Celsius, protected from light.

Administration Instructions

• • To be administered as a slow IV infusion.
• • To be used immediately after reconstitution.